Owner Mayo Foundation for Medical Education and Research

Inventors Rodriguez, Moses; Miller, David J.; Pease, Larry R.

Agent Madderns

Pub. Number AU-B-2000261978

PCT Pub. Number WO01/85797

Priority 09568351 10.05.00 US

Filing date 30 May 2000

Wipo publication date 20 November 2001

Acceptance publication date 6 July 2006

C07K 16/06 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - from serum

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 25/02 (2006.01) Drugs for disorders of the nervous system

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

C12N 5/08 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay